Quantbot Technologies LP Increases Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Quantbot Technologies LP grew its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 34.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 107,418 shares of the company’s stock after acquiring an additional 27,732 shares during the quarter. Quantbot Technologies LP’s holdings in Ryan Specialty were worth $7,131,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Hollencrest Capital Management acquired a new position in shares of Ryan Specialty during the third quarter worth about $25,000. Assetmark Inc. acquired a new position in Ryan Specialty during the third quarter worth $34,000. GAMMA Investing LLC lifted its holdings in Ryan Specialty by 96.4% in the second quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after acquiring an additional 297 shares during the period. Crewe Advisors LLC purchased a new stake in shares of Ryan Specialty during the 2nd quarter worth $39,000. Finally, Rothschild Investment LLC purchased a new position in shares of Ryan Specialty in the 2nd quarter valued at about $87,000. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty Stock Up 1.4 %

Shares of NYSE RYAN opened at $74.59 on Tuesday. Ryan Specialty Holdings, Inc. has a 52-week low of $41.49 and a 52-week high of $75.39. The stock has a market capitalization of $19.53 billion, a PE ratio of 96.87, a P/E/G ratio of 1.67 and a beta of 0.62. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a fifty day moving average of $69.27 and a 200-day moving average of $62.80.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company’s revenue for the quarter was up 20.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.32 EPS. On average, analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current year.

Ryan Specialty Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be given a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 0.59%. The ex-dividend date is Tuesday, November 12th. Ryan Specialty’s payout ratio is currently 57.14%.

Analysts Set New Price Targets

Several research analysts have weighed in on RYAN shares. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th. UBS Group upped their target price on Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a report on Tuesday, August 13th. Bank of America raised their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, October 10th. JPMorgan Chase & Co. increased their target price on Ryan Specialty from $54.00 to $56.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. Finally, Barclays boosted their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Ryan Specialty currently has an average rating of “Hold” and an average price target of $71.67.

Insider Activity

In other news, EVP Mark Stephen Katz sold 14,790 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. The trade was a 54.42 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Nicholas Dominic Cortezi sold 5,375 shares of the firm’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $64.73, for a total transaction of $347,923.75. Following the sale, the director now directly owns 2,685 shares of the company’s stock, valued at approximately $173,800.05. The trade was a 66.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 11.10% of the company’s stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.